Here's Shares Agios Pharmaceuticals: 2026 Outlook and Rally
Biotech investors watched Agios Pharmaceuticals spark a notable rally after key quarterly results and a strong Aqvesm...
Life changes demand budget revisions. Set a cadence to review income, expenses, and goals, then update categories accordingly.
18,448 articlesBiotech investors watched Agios Pharmaceuticals spark a notable rally after key quarterly results and a strong Aqvesm...
A software stock that doubled since April caught my eye for reasons beyond hype. In this guide, I explain the growth ...
Insider sales in biotech can spark questions about a company’s future. This guide breaks down what to watch, how to r...
Novo Nordisk faces challenges, but three strong catalysts could propel the stock higher. This article breaks down the...
Lucid delivered higher volumes and nudged toward improving efficiency, signaling a potential turn in its long EV jour...
A prominent real estate fund made a bold $5 million move on InvenTrust Properties as the stock trailed the S&P 500. T...
June begins with a surprising move in the stock market today, june as AMC Entertainment surges on stronger May attend...
A high-stakes security scare underscores how drone threats can touch crypto events. This article breaks down what hap...
Microsoft is not shrinking its ambitions. In this deep dive, we explore how the tech giant aims to reset its gaming d...
A near-40 couple carries $86,000 in debt as they earn $200,000 a year and wonder if they should invest now or pay dow...
Oil markets are tight and geopolitics keep the pressure on. This guide weighs whether SHEL stock can weather the sque...
When a Materion director trims stake, investors should look beyond the sale. The bigger signal may lie in the company...